Latest Articles
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider
Published: Feb. 18, 2026, 3:28 p.m.
Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider
Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider
Published: Feb. 18, 2026, 3:28 p.m.
FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider
FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Feb. 18, 2026, 3:18 p.m.
She filed a workplace discrimination lawsuit for endometriosis − and won - USA Today
She filed a workplace discrimination lawsuit for endometriosis − and won USA Today
Published: Feb. 18, 2026, 3:14 p.m.
How EndoFound's 17th Annual Patient Day is Reframing Endometriosis as a Critical Public Health Issue - Endometriosis Foundation of America
How EndoFound's 17th Annual Patient Day is Reframing Endometriosis as a Critical Public Health Issue Endometriosis Foundation of America
Published: Feb. 18, 2026, 2:13 p.m.
Aprea reports second partial response in endometrial cancer trial - Investing.com
Aprea reports second partial response in endometrial cancer trial Investing.com
Published: Feb. 18, 2026, 1:42 p.m.
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement - The AI Journal
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement The AI Journal
Published: Feb. 18, 2026, 1:25 p.m.
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement - Business Wire
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement Business Wire
Published: Feb. 18, 2026, 1 p.m.
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - European Medical Journal
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk European Medical Journal
Published: Feb. 18, 2026, noon
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - EMJ | Elevating the quality of healthcare globally
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk EMJ | Elevating the quality of healthcare globally
Published: Feb. 18, 2026, noon
Link copied to clipboard!